Senseonics (NYSE:SENS) said today that Blue Cross Blue Shield of Massachusetts and Idaho now provide coverage for the implantable Eversense continuous glucose monitor. The company’s Eversense device includes a fluorescence-based sensor, a mobile app and a transmitter. Senseonics’ touts its system as being the first with a long-term, implantable CGM sensor, as well as the first […]
Insulet prices $700m offering
Insulet (NSDQ:PODD) today priced a private placement of $700 million in convertible senior notes due 2026. The offering is slated to close on Sept. 6. The Acton, Mass.-based company said in a press release it also gave initial purchasers an option to buy up to an additional $100 million in notes. Get the full story at our sister […]
Boston Scientific closes $4B BTG purchase
Boston Scientific (NYSE:BSX) said today that it finished its $4 billion acquisition of BTG (LN:BTG). The Marlborough, Mass.-based medtech giant reported that the transaction will be immaterial to adjusted earnings per share this year, thanks to – among other factors – the deal closing later than initially anticipated. To satisfy antitrust regulators, Boston Scientific is […]
Insulet touts full market launch of mobile apps for Omnipod Dash
Insulet (NSDQ:PODD) touted the full market launch of the Omnipod Display and Omnipod View apps for people using the company’s Omnipod Dash system. The Display app enables users to display data from their Personal Diabetes Manager device onto their smartphones. The View app gives caregivers and family members the option to remotely monitor Omnipod Dash system […]
Nevro beats the Street with Q2 results
Shares in Nevro (NYSE:NVRO) rose this week after the medical device maker topped expectations on Wall Street with its second-quarter financial results. The Redwood City, Calif.-based company posted a net loss of -$28 million on sales of $93.6 million for the three months ended June 30. Compared with the same period last year, Nevro’s revenue fell […]
On mixed Q2 results, Glaukos announces Avedro buy
Glaukos (NYSE:GKOS) posted its second-quarter financial results this week and reported that it plans to acquire Avedro in an effort to build out its corneal health franchise. Avedro develops single-use drug formulations designed to strengthen corneal tissue and stop the progression of a degenerative corneal ectatic disease known as keratoconus. According to the Mass.-based company, the total U.S. […]
Siemens to acquire Corindus in $1.1B deal
Corindus Vascular Robotics (NYSE:CVRS) reported its second-quarter financials today, revealing that it inked a deal to be acquired by Siemens Healthineers (NYSE:SI) in an all-cash deal valued at roughly $1.1 billion. Siemens Medical Solution, a subsidiary of Siemens Healthineers, is slated to acquire all issued and outstanding common stock in Corindus for $4.28 apiece in cash. The […]
Applying AI in the ER with CEO Gene Saragnese | DeviceTalks Podcast
MaxQ AI chairman & CEO Gene Saragnese talked to reporter Sarah Faulkner about the company’s software that uses AI to interpret medical images and patient data. Want to see these interviews live? Join us at DeviceTalks. Sarah: Digital health, artificial intelligence and machine learning – these terms represent a lot of the buzz emerging from […]
Boston Scientific aims for personalized Parkinson’s therapy with Vercise DBS
Dr. Rafael Carbunaru and his team at Boston Scientific (NYSE:BSX) have spent the last twenty years building, among other things, the Vercise deep brain stimulation system in an attempt to deliver precise, personalized therapy for people with Parkinson’s disease. “It’s a labor of love,” the VP of R&D told MassDevice.com. Carbunaru estimated there are roughly 1.2 […]
Avoset to develop infusion pump with unnamed pharma giant
Avoset Health said this week that it plans to develop a connected infusion pump with an unnamed pharmaceutical company. The product is set to debut in early 2021. The company touted that its technology allows physicians and pharmacists to track when patients receive infusions, how much drug was infused and which patients need additional intervention. Get […]
Abbott recalls select Ellipse ICDs due to damaged wires
Abbott (NYSE:ABT) began voluntarily recalling 204 Ellipse implantable cardioverter defibrillators in June to prevent the use of devices that may have a vulnerability in the electronic circuitry due to damaged wires, according to a recently-filed urgent field safety notice. The company stressed that it has not received any product performance complaints or adverse patient events related […]
- 1
- 2
- 3
- …
- 252
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube